Multiple Sclerosis (MS) is an inflammatory disease of the Central Nerveous System (CNS). That means MS is a disorder of the brain and spinal cord caused by progressive damage to the outer covering of nerve cells (myelin). This results in decreased nerve functioning which can lead to a variety of symptoms. MS is indicated by three main forms:

1. Relapsing-Remitting (RR):
This is characterised by relapses during which time new symptoms can appear and old ones resurface or worsen. The relapses are followed by periods of remission, during which time the person fully or partially recovers from the deficits acquired during the relapse.

2. Primary Progressive (PP):

This type of MS is characterised by a gradual progression of the disease from its onset with no remissions at all.
Primary Progressive MS often migrates into the brain, but is less likely to damage brain areas than relapsing/remitting or secondary progressive.

3. Secondary Progressive (SP):

The secondary progessive phase is characterised by a gradual worsening of the disease with no periods of remission in between. In the early phases of Secondary Progressive, the person may still experience periods of increased disease activity similar to relapses but after a while these merge into a general progression.
Therapy